Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-10-004240)

Filing Details

Accession Number:: 0001179110-10-004240
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-02 12:00:00
Reporting Period:: 2010-02-26

Filing Date:: 2010-03-02
Accepted Time:: 2010-03-02 18:52:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800	Abbott Laboratories	ABT	Pharmaceutical Preparations (2834)	360698440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1360215	Olivier Bohuon	100 Abbott Park Road Abbott Park IL 60064-6400	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares Without Par Value	Acquisiton	2010-02-26	26,667	$0.00	123,843	No	4	A	Direct
Common Shares Without Par Value	Disposition	2010-02-26	3,634	$54.32	120,209	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	100	$54.32	120,109	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	400	$54.32	119,709	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	1,200	$54.32	118,509	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	3,500	$54.33	115,009	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	300	$54.33	114,709	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	100	$54.33	114,609	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	1,100	$54.33	113,509	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	100	$54.33	113,409	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	100	$54.33	113,309	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	2,600	$54.33	110,709	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-26	200	$54.33	110,509	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.